Cerebrolysin: Patient Information & Safety Notes
Also known as CERE
Other names: cere, porcine-brain-hydrolysate
Cerebrolysin is a mixture of peptides and amino acids derived from porcine (pig) brain tissue. It has been studied in Eastern European and Chinese clinical trials for stroke recovery, traumatic brain injury, and dementia. It is NOT approved by the FDA in the United States.
In plain language
What Cerebrolysin is used for
- Investigated in some countries for post-stroke recovery, TBI, and dementia
Taking this medicine
How it is administered
- Intravenous or intramuscular injection in countries where an authorized product is used
Read before you decide
Risks and precautions
Risks and warnings
- Dizziness, headache, nausea
- Loss of appetite
- Allergic reactions possible
Who should not take it
- Epilepsy
- Severe kidney disease
- Pregnancy
Common questions
Patient questions
Is Cerebrolysin approved in the US?
No. Cerebrolysin is not FDA-approved in the United States for any indication. It is available in some other countries. US clinical trials are limited. Individuals with stroke, TBI, or dementia should consult a neurologist for FDA-approved or evidence-based treatments.
Related medications
Explore treatment hubs
This information is educational — not medical advice.
This page is provided for general educational purposes and summarizes publicly available data from sources such as the U.S. Food & Drug Administration. It is not a substitute for the judgment of a licensed clinician and should not be used to start, stop, or change any medication. It may be incomplete or out of date, and individual circumstances vary. Always talk with your prescriber or pharmacist about your specific medications and health conditions. If you think you may have a medical emergency, call 911.
Sources & References
Learn more about where our data comes from and how we write and review medical content.